Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Apoteket gets new vice CEO

The Swedish government company Apoteket has recently appointed a vice CEO.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Respiratorius hunts millions

The biopharmaceutical company Respiratorius has got a new CEO, who starts a public new share issue to catch almost SEK ten million.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Swedish multi competent machine soon launched

The Swedish company Biosensor will launch new equipment able to detect twelve different narcotics and explosives simultaneously.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a small illuminating lens.

Polymer guru new dean at DTU

The Technical University of Denmark, DTU, has appointed a well-known profile from the Polymer Center as a new dean.

Pronova Biopharma grows

Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark

Crafoord Prize to an American and two Japanese

Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

Ten recieve the Venture Cup West Prize

At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.

LEO Pharma - International Clinical Trial Manager

Norwegian cancer therapy leaves phase II

New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Norwegian entrance in EU technology network

The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

New CEO to Medivir

The Board of the Swedish biotech company Medivir has appointed the successor to the current CEO Lars Adlersson.